enrofloxacin has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Barr, JJ; Dai, J; Li, J; Ren, J; Subedi, D; Tang, F; Wang, Y; Wu, J; Xue, F | 1 |
| Agius, JE; Emery, JP; Phalen, DN; Rose, K | 1 |
| Kim, Y; Kweon, MN; Lee, SH; Lee, YS; Park, YY; Yang, JY | 1 |
| Chu, F; Dahlgren, RA; Du, L; Gu, H; Li, Y; Ma, Y; Wang, H; Wang, X; Zheng, Y | 1 |
| Bushman, W; Hutson, PR; Wong, L | 1 |
| Berndt, A; Liebler-Tenorio, E; Lohr, M; Ostermann, C; Prohl, A; Reinhold, P; Rothe, M; Sachse, K; Schroedl, W; Schubert, E | 1 |
| Becker, KJ; Fecteau, L; Kunze, A; Lee, B; Skerrett, S; Zierath, D | 1 |
| Bauquier, SH; Cook, MJ; Jiang, JL; Lai, A | 1 |
| de la Fuente, AJ; Fossum, C; Sjölund, M; Wallgren, P | 1 |
| Avci, GE; Bulbul, A; Elmas, M; Er, A; Tras, B; Uney, K; Yazar, E | 1 |
| Berkvens, D; Delespaux, V; Geerts, S; Marcotty, T; Roy, K; Speybroeck, N; Van den Bossche, P; Vitouley, HS | 1 |
| Griffin, AJ; Li, LX; McSorley, SJ; Pabst, O; Voedisch, S | 1 |
13 other study(ies) available for enrofloxacin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Phage Cocktail Targeting STEC O157:H7 Has Comparable Efficacy and Superior Recovery Compared with Enrofloxacin in an Enteric Murine Model.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Disease Models, Animal; Enrofloxacin; Escherichia coli Infections; Escherichia coli O157; Mice; Shiga-Toxigenic Escherichia coli | 2022 |
Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Models, Animal; Enrofloxacin; Enterococcus; Humans; Lizards | 2021 |
The resident pathobiont Staphylococcus xylosus in Nfkbiz-deficient skin accelerates spontaneous skin inflammation.
Topics: Adaptor Proteins, Signal Transducing; Animals; CD4-Positive T-Lymphocytes; Cephalexin; Dermatitis; Disease Models, Animal; Enrofloxacin; Humans; Immunoglobulin E; Mice; Nuclear Proteins; Sequence Analysis, DNA; Skin; Staphylococcal Infections; Staphylococcus; Symbiosis | 2017 |
Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following β-diketone antibiotic exposure to F0-zebrafish (Danio rerio).
Topics: Animals; Anti-Bacterial Agents; Atherosclerosis; Chlortetracycline; Cholesterol; Ciprofloxacin; Computational Biology; Disease Models, Animal; Doxycycline; Enrofloxacin; Female; Hyperlipidemias; Larva; Lipid Metabolism; Male; MicroRNAs; Ofloxacin; Oxytetracycline; Peroxisome Proliferator-Activated Receptors; Triglycerides; Up-Regulation; Zebrafish; Zebrafish Proteins | 2018 |
Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Chromatography, High Pressure Liquid; Collagen; Disease Models, Animal; Enrofloxacin; Escherichia coli Infections; Fibrosis; Fluoroquinolones; Hydroxyproline; Male; Mice, Inbred C3H; Prostate; Prostatitis | 2015 |
Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cattle; Chlamydophila psittaci; Disease Models, Animal; Enrofloxacin; Erythromycin; Fluoroquinolones; Inflammation; Macrolides; Male; Psittacosis; Rifampin | 2015 |
The contribution of antibiotics, pneumonia and the immune response to stroke outcome.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Temperature; Body Weight; Cephalosporins; Cytokines; Disease Models, Animal; Enrofloxacin; Fluoroquinolones; Lymphocytes; Male; Myelin Basic Protein; Nervous System Diseases; Pneumonia; Rats; Rats, Inbred Lew; Staphylococcus aureus; Statistics, Nonparametric; Stroke | 2016 |
Clonic Seizures in GAERS Rats after Oral Administration of Enrofloxacin.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Brain; Disease Models, Animal; Electroencephalography; Enrofloxacin; Epilepsy, Absence; Female; Fluoroquinolones; Genetic Predisposition to Disease; Pilot Projects; Rats; Rats, Wistar; Seizures | 2016 |
Responses of pigs to a re-challenge with Actinobacillus pleuropneumoniae after being treated with different antimicrobials following their initial exposure.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Disease Models, Animal; Enrofloxacin; Euthanasia, Animal; Fluoroquinolones; Penicillins; Respiratory Tract Diseases; Specific Pathogen-Free Organisms; Swine; Swine Diseases; Tetracycline | 2009 |
Effects of drugs used in endotoxic shock on oxidative stress and organ damage markers.
Topics: Animals; Ascorbic Acid; Autoanalysis; Biomarkers; Clonixin; Dexamethasone; Dinoprost; Disease Models, Animal; Drug Therapy, Combination; Enrofloxacin; Enzyme-Linked Immunosorbent Assay; Female; Fluoroquinolones; Heart Diseases; Kidney Diseases; Lipopolysaccharides; Liver Diseases; Male; Malondialdehyde; Multiple Organ Failure; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Shock, Septic; Superoxide Dismutase; Time Factors | 2010 |
Chemosensitization of Trypanosoma congolense strains resistant to isometamidium chloride by tetracyclines and enrofloxacin.
Topics: Animals; Antiprotozoal Agents; Cattle; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Mice; Parasitemia; Phenanthridines; Survival Analysis; Tetracyclines; Treatment Outcome; Trypanosoma congolense; Trypanosomiasis, African | 2010 |
Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.
Topics: Animals; Anti-Bacterial Agents; Cell Separation; Disease Models, Animal; Enrofloxacin; Flow Cytometry; Fluoroquinolones; Intestine, Small; Lymph Nodes; Mesentery; Mice; Mice, Inbred C57BL; Monocytes; Recurrence; Salmonella Infections, Animal; Salmonella typhi | 2011 |